Page All:
Page 1
Wireless Monitoring Platform Transforming Patient Care Around the World
OXFORD, England, May 31, 2016 /PRNewswire/ --
- Isansys [http://www.dailymail.co.uk/sciencetech/apple/index.html ]Â Lifecare, a new
generation digital healthcare company, sees rapidly increasing global demand for its
Patient Status Engine wireless patient monitoring platform, as it ships more systems
to hospitals in India, Germany, Scotland and Norway
- The company's 2nd generation system, launched earlier this year, is now being used in
ground-breaking clinical work [http://www.isansys.com/en/about-us/who-we-work-with ]
around the world
- This new technology significantly enhances the user experience and provides higher
quality data enabling earlier detection of deterioration or improvement in a
patients' conditions. Healthcare providers can now analyse more patients' data in
real-time, and using the inbuilt early warning scores can track the status of their
patients at all times both in hospital and at homeÂ
Demand for real-time continuous data, including personal health information, early
warning scores [http://www.isansys.com/content2012/display_news.php?id=54 ], and alerting
when a patient's condition is deteriorating, is driving the market for complete monitoring
systems in hospital and home care settings globally.
(Photo:
http://photos.prnewswire.com/prnh/20160527/373122 )
Isansys Lifecare, the market-leader in real-time patient data capture and analysis
systems, today announced that demand for its complete, scalable, Patient Status Engine
platforms has exceeded expectations as it has shipped systems to Norway, Germany, Scotland
and India and is currently processing more orders for systems around the world.
Installation, including integration with a provider's IT system, has been designed to
be simple and fast, usually completed within one day, thus allowing providers to deploy
the system almost immediately and start collecting patient data. The objectives for each
of the providers are to improve efficiencies and to provide accurate early warning
indicators of adverse events without the additional labour costs associated with manual
observations.
Dr Line Pedersen, who is leading the work at Sorlandet Hospital Group, Norway where
Isansys has just installed a number of systems, said: "This is an important project to
improve patient safety. Through the use of the Isansys patient monitoring equipment across
our hospital, I believe we can both reduce mortality and save money. We are looking
forward to meeting our goal of delivering an exceptional patient care experience."
Keith Errey, CEO of Isansys, said: "We are delighted to be deploying our systems to
hospital and healthcare providers globally and that the value of this type of technology
is now being recognised by people all around the world - the demand has completely
surpassed our expectations. The PSE is an ideal match for a suite of healthcare solutions
and will allow each of these countries to harness a wealth of new opportunities for
improved clinical outcomes, reduced overall cost and increased revenues.
"Our scalable and low-cost technology and service models offer clear benefits that
make them uniquely suitable for these vast markets. We hope that by installing our systems
in these hospitals and communities we can empower them to provide enhanced levels of
proactive care.
"Automatic data capture addresses a whole range of issues relating to the pressures on
nurses and greatly improves in-ward efficiencies compared with manual methods, including
manual electronic observation systems. From any point of view, including cost, the PSE is
very much the future of patient monitoring."
The PSE provides a complete end-to-end platform to continuously and wirelessly capture,
collect, store and interpret vital sign and other physiological data. The Class IIA,
CE-marked platform, uses the Lifetouch, Lifetemp and other unobtrusive wireless, wearable
sensors to collect data directly from the patient. The system analyses the ECG of every
heartbeat to provide continuous heart rate, respiration rate, heart rate variability and
other cardiac parameters such as arrhythmias, and uses other sensors for continuous oxygen
saturation, PPG, blood pressure and temperature. This rich ensemble of physiological data
is analysed and simplified to allow doctors and nurses to monitor patients better, more
closely, and more efficiently. It is clinically proven to assist in early detection of
patient deterioration and helping to prevent adverse events.
The Patient Status Engine is both a medical device and a platform technology. The data
that is collected can be used to address a range of clinical needs and is not focussed on
any one condition or disease. For instance, each country where the PSE has been shipped is
using the platform to focus on different patient care pathway.
- In Norway the PSE is initially being used for automatic multiple vital sign data
collection and analysis for early warning scores for early detection of patient
deterioration Â
- In Germany, clinicians are focussed on getting the patient out of hospital in the
quickest time possible. This reduces the number of bed days for the patient and
provides an opportunity for additional income for the hospital provider Â
- In Scotland clinicians will use the PSE to look for asymptomatic atrial fibrillation
in a long term screening trial and in a separate project, to monitor premature babies.
The PSE is the only wireless monitoring system approved for paediatric use. Â
- In India, Isansys is working with a number of leading hospital groups to provide early
warning scores and other quantitative measures to improve patient outcomes, reduce
costs for patient-payers, increase revenues for providers and provide out of hospital
care. Â
Rebecca Weir, cofounder and Director of Business Development at Isansys, said: "We
developed the PSE [http://www.isansys.com/en/products/PSE ] over the last six years by
working closely with clinicians and nurses and listening to their issues and needs. It is
now really encouraging to see how much of a demand there is for the system, as clinicians
and providers in many countries are recognising that these new data driven methods are now
available for better clinical practice, improved patient care and efficiency gains across
the whole healthcare delivery spectrum."
Â
Press Contacts:Â
Georgina Horton, PR and Marketing ExecutiveÂ
Tel: +44(0)1235-436229Â
Mob: +44(0)7852-181898Â
Email: georgina.horton@isansys.com  Â
Â
Photo:
http://photos.prnewswire.com/prnh/20160527/373122
Photo:http://photos.prnewswire.com/prnh/20160527/373122
http://photoarchive.ap.org/
Photo:http://photos.prnewswire.com/prnh/20160527/373122
http://photoarchive.ap.org/
Isansys Lifecare
Wireless Monitoring Platform Transforming Patient Care Around the World
OXFORD, England, May 31, 2016 /PRNewswire/ --
- Isansys [http://www.dailymail.co.uk/sciencetech/apple/index.html ]Â Lifecare, a new
generation digital healthcare company, sees rapidly increasing global demand for its
Patient Status Engine wireless patient monitoring platform, as it ships more systems
to hospitals in India, Germany, Scotland and Norway
- The company's 2nd generation system, launched earlier this year, is now being used in
ground-breaking clinical work [http://www.isansys.com/en/about-us/who-we-work-with ]
around the world
- This new technology significantly enhances the user experience and provides higher
quality data enabling earlier detection of deterioration or improvement in a
patients' conditions. Healthcare providers can now analyse more patients' data in
real-time, and using the inbuilt early warning scores can track the status of their
patients at all times both in hospital and at homeÂ
Demand for real-time continuous data, including personal health information, early
warning scores [http://www.isansys.com/content2012/display_news.php?id=54 ], and alerting
when a patient's condition is deteriorating, is driving the market for complete monitoring
systems in hospital and home care settings globally.
(Photo:
http://photos.prnewswire.com/prnh/20160527/373122 )
Isansys Lifecare, the market-leader in real-time patient data capture and analysis
systems, today announced that demand for its complete, scalable, Patient Status Engine
platforms has exceeded expectations as it has shipped systems to Norway, Germany, Scotland
and India and is currently processing more orders for systems around the world.
Installation, including integration with a provider's IT system, has been designed to
be simple and fast, usually completed within one day, thus allowing providers to deploy
the system almost immediately and start collecting patient data. The objectives for each
of the providers are to improve efficiencies and to provide accurate early warning
indicators of adverse events without the additional labour costs associated with manual
observations.
Dr Line Pedersen, who is leading the work at Sorlandet Hospital Group, Norway where
Isansys has just installed a number of systems, said: "This is an important project to
improve patient safety. Through the use of the Isansys patient monitoring equipment across
our hospital, I believe we can both reduce mortality and save money. We are looking
forward to meeting our goal of delivering an exceptional patient care experience."
Keith Errey, CEO of Isansys, said: "We are delighted to be deploying our systems to
hospital and healthcare providers globally and that the value of this type of technology
is now being recognised by people all around the world - the demand has completely
surpassed our expectations. The PSE is an ideal match for a suite of healthcare solutions
and will allow each of these countries to harness a wealth of new opportunities for
improved clinical outcomes, reduced overall cost and increased revenues.
"Our scalable and low-cost technology and service models offer clear benefits that
make them uniquely suitable for these vast markets. We hope that by installing our systems
in these hospitals and communities we can empower them to provide enhanced levels of
proactive care.
"Automatic data capture addresses a whole range of issues relating to the pressures on
nurses and greatly improves in-ward efficiencies compared with manual methods, including
manual electronic observation systems. From any point of view, including cost, the PSE is
very much the future of patient monitoring."
The PSE provides a complete end-to-end platform to continuously and wirelessly capture,
collect, store and interpret vital sign and other physiological data. The Class IIA,
CE-marked platform, uses the Lifetouch, Lifetemp and other unobtrusive wireless, wearable
sensors to collect data directly from the patient. The system analyses the ECG of every
heartbeat to provide continuous heart rate, respiration rate, heart rate variability and
other cardiac parameters such as arrhythmias, and uses other sensors for continuous oxygen
saturation, PPG, blood pressure and temperature. This rich ensemble of physiological data
is analysed and simplified to allow doctors and nurses to monitor patients better, more
closely, and more efficiently. It is clinically proven to assist in early detection of
patient deterioration and helping to prevent adverse events.
The Patient Status Engine is both a medical device and a platform technology. The data
that is collected can be used to address a range of clinical needs and is not focussed on
any one condition or disease. For instance, each country where the PSE has been shipped is
using the platform to focus on different patient care pathway.
- In Norway the PSE is initially being used for automatic multiple vital sign data
collection and analysis for early warning scores for early detection of patient
deterioration Â
- In Germany, clinicians are focussed on getting the patient out of hospital in the
quickest time possible. This reduces the number of bed days for the patient and
provides an opportunity for additional income for the hospital provider Â
- In Scotland clinicians will use the PSE to look for asymptomatic atrial fibrillation
in a long term screening trial and in a separate project, to monitor premature babies.
The PSE is the only wireless monitoring system approved for paediatric use. Â
- In India, Isansys is working with a number of leading hospital groups to provide early
warning scores and other quantitative measures to improve patient outcomes, reduce
costs for patient-payers, increase revenues for providers and provide out of hospital
care. Â
Rebecca Weir, cofounder and Director of Business Development at Isansys, said: "We
developed the PSE [http://www.isansys.com/en/products/PSE ] over the last six years by
working closely with clinicians and nurses and listening to their issues and needs. It is
now really encouraging to see how much of a demand there is for the system, as clinicians
and providers in many countries are recognising that these new data driven methods are now
available for better clinical practice, improved patient care and efficiency gains across
the whole healthcare delivery spectrum."
Â
Press Contacts:Â
Georgina Horton, PR and Marketing ExecutiveÂ
Tel: +44(0)1235-436229Â
Mob: +44(0)7852-181898Â
Email: georgina.horton@isansys.com  Â
Â
Photo:
http://photos.prnewswire.com/prnh/20160527/373122
Photo:http://photos.prnewswire.com/prnh/20160527/373122
http://photoarchive.ap.org/
Photo:http://photos.prnewswire.com/prnh/20160527/373122
http://photoarchive.ap.org/
Isansys Lifecare